PMID- 12835669 OWN - NLM STAT- MEDLINE DCOM- 20030826 LR - 20220225 IS - 1474-175X (Print) IS - 1474-175X (Linking) VI - 3 IP - 7 DP - 2003 Jul TI - Molecular mechanisms of glioma invasiveness: the role of proteases. PG - 489-501 AB - The invasive nature of brain-tumour cells makes an important contribution to the ineffectiveness of current treatment modalities, as the remaining tumour cells inevitably infiltrate the surrounding normal brain tissue, which leads to tumour recurrence. Such local invasion remains an important cause of mortality and underscores the need to understand in more detail the mechanisms of tumour invasiveness. Several proteases influence the malignant characteristics of gliomas--could their inhibition prove to be a useful therapeutic strategy? FAU - Rao, Jasti S AU - Rao JS AD - Program of Cancer Biology, Department of Neurosurgery, University of Illinois College of Medicine-Peoria, 1 Illini Drive, Peoria, Illinois 61656, USA. jsrao@uic.edu LA - eng PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PT - Review PL - England TA - Nat Rev Cancer JT - Nature reviews. Cancer JID - 101124168 RN - 0 (PLAUR protein, human) RN - 0 (Receptors, Cell Surface) RN - 0 (Receptors, Urokinase Plasminogen Activator) RN - EC 3.4.- (Endopeptidases) RN - EC 3.4.21.- (Plasminogen Activators) RN - EC 3.4.21.73 (Urokinase-Type Plasminogen Activator) RN - EC 3.4.22.1 (Cathepsin B) RN - EC 3.4.24.- (Matrix Metalloproteinases) SB - IM CIN - Nat Rev Cancer. 2003 Jul;3(7):doi:10.1038/nrc1121-c1. PMID: 19006840 MH - Cathepsin B/metabolism MH - Central Nervous System Neoplasms/*metabolism/*pathology/physiopathology MH - Endopeptidases/*physiology MH - Glioma/*metabolism/*pathology/physiopathology MH - Humans MH - Matrix Metalloproteinases/metabolism MH - Neoplasm Invasiveness MH - Neoplasm Recurrence, Local/metabolism MH - Plasminogen Activators/metabolism MH - Receptors, Cell Surface/metabolism MH - Receptors, Urokinase Plasminogen Activator MH - Urokinase-Type Plasminogen Activator/metabolism RF - 146 EDAT- 2003/07/02 05:00 MHDA- 2003/08/27 05:00 CRDT- 2003/07/02 05:00 PHST- 2003/07/02 05:00 [pubmed] PHST- 2003/08/27 05:00 [medline] PHST- 2003/07/02 05:00 [entrez] AID - nrc1121 [pii] AID - 10.1038/nrc1121 [doi] PST - ppublish SO - Nat Rev Cancer. 2003 Jul;3(7):489-501. doi: 10.1038/nrc1121.